首页>Journal of drugs in dermatology: JDD>Efficacy and Safety of Apremilast in Systemic- and Biologic-Naive Patients With Moderate Plaque Psoriasis: 52-Week Results of UNVEIL
Efficacy and Safety of Apremilast in Systemic- and Biologic-Naive Patients With Moderate Plaque Psoriasis: 52-Week Results of UNVEIL
作者单位：Univ Louisville, Forefront Dermatol, Louisville, KY 40292 USA[1]Icahn Sch Med Mt Sinai, New York, NY 10029 USA[2]Henry Ford Hlth Syst, West Bloomfield, MI 48322 USA[3]Celgene Corp, Summit, NJ USA[4]Univ Utah, Salt Lake City, UT USA[5]Psoriasis Treatment Ctr Cent New Jersey, East Windsor, NJ USA[6]
换一批
